Genmab, A/S

Antibody developer appoints Bo Kruse as interim CFO

Published in Hospital and Nursing Home Week, September 8th, 2005

Genmab, A/S, announced the appointment of Bo Kruse as vice president and interim CFO.

Kruse was formerly Genmab's vice president (finance) and chief accounting officer and will now be responsible for overseeing the finance and accounting activities at the company.

Prior to joining Genmab in 2000, Kruse worked as a senior associate at PricewaterhouseCoopers.

Kruse replaces Alberto Elli, who is no longer acting as CFO.

Genmab, A/S, is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases.

This article was prepared by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week

Source: Hospital and Nursing Home Week (2005-09-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry